tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam price target raised to $570 from $500 at H.C. Wainwright
The FlyAlnylam price target raised to $570 from $500 at H.C. Wainwright
2d ago
ALNY
Alnylam Pharma: Strong Commercial Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
Alnylam Pharma: Strong Commercial Performance and Promising Pipeline Drive Buy Rating
2d ago
ALNY
Alnylam Pharma: Strong Growth Prospects and Transition to Profitability Support Buy Rating
PremiumRatings
Alnylam Pharma: Strong Growth Prospects and Transition to Profitability Support Buy Rating
2d ago
ALNY
Alnylam price target raised to $475 from $348 at JPMorgan
PremiumThe Fly
Alnylam price target raised to $475 from $348 at JPMorgan
3d ago
ALNY
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
5d ago
AVB
BAX
Alnylam upgraded to Peer Perform from Underperform at Wolfe Research
PremiumThe FlyAlnylam upgraded to Peer Perform from Underperform at Wolfe Research
5d ago
ALNY
Oppenheimer upgrades Alnylam to Outperform on Amvuttra launch
Premium
The Fly
Oppenheimer upgrades Alnylam to Outperform on Amvuttra launch
5d ago
ALNY
Alnylam upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Alnylam upgraded to Outperform from Perform at Oppenheimer
5d ago
ALNY
Alnylam Pharma: Hold Rating Amid Strong Sales and Elevated Costs
PremiumRatings
Alnylam Pharma: Hold Rating Amid Strong Sales and Elevated Costs
5d ago
ALNY
Alnylam’s Q2 2025 Earnings Call Highlights Robust Growth
PremiumCompany Announcements
Alnylam’s Q2 2025 Earnings Call Highlights Robust Growth
7d ago
ALNY
Alnylam price target raised to $459 from $385 at Truist
PremiumThe Fly
Alnylam price target raised to $459 from $385 at Truist
8d ago
ALNY
Alnylam price target raised to $450 from $342 at Scotiabank
PremiumThe Fly
Alnylam price target raised to $450 from $342 at Scotiabank
8d ago
ALNY
Alnylam price target raised to $424 from $370 at Raymond James
PremiumThe FlyAlnylam price target raised to $424 from $370 at Raymond James
8d ago
ALNY
Alnylam price target raised to $449 from $304 at Piper Sandler
Premium
The Fly
Alnylam price target raised to $449 from $304 at Piper Sandler
8d ago
ALNY
Alnylam price target raised to $550 from $403 at UBS
Premium
The Fly
Alnylam price target raised to $550 from $403 at UBS
8d ago
ALNY
Alnylam price target raised to $415 from $390 at Canaccord
PremiumThe Fly
Alnylam price target raised to $415 from $390 at Canaccord
8d ago
ALNY
Alnylam Pharma: Strong Financials and Strategic Advancements Drive Buy Rating
PremiumRatings
Alnylam Pharma: Strong Financials and Strategic Advancements Drive Buy Rating
8d ago
ALNY
Alnylam price target raised to $405 from $312 at Morgan Stanley
PremiumThe Fly
Alnylam price target raised to $405 from $312 at Morgan Stanley
8d ago
ALNY
Cautious Optimism: Alnylam Pharma’s Strong TTR Franchise Growth and Hold Rating
PremiumRatings
Cautious Optimism: Alnylam Pharma’s Strong TTR Franchise Growth and Hold Rating
8d ago
ALNY
Alnylam price target raised to $460 from $329 at Barclays
PremiumThe FlyAlnylam price target raised to $460 from $329 at Barclays
8d ago
ALNY
Alnylam Pharmaceuticals Reports Strong Q2 2025 Growth
Premium
Company Announcements
Alnylam Pharmaceuticals Reports Strong Q2 2025 Growth
8d ago
ALNY
Alnylam Pharma’s Strong Financial Performance and Strategic Partnerships Justify Buy Rating
Premium
Ratings
Alnylam Pharma’s Strong Financial Performance and Strategic Partnerships Justify Buy Rating
8d ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >